This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on ISI (3)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in this journal  Topic Collections  • Adverse Effects  • Alert me on articles by topic

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

I am writing in response to the case report of Drs Gavras and Gavras titled "Are Patients Who Develop Angioedema With ACE Inhibition at Risk of the Same Problem With AT1 Receptor Blockers?"¹ The authors report a small sampling of patients who had angioedema with ACE inhibition, but who subsequently tolerated ARB medications without adverse effects. They state that there findings "should alleviate the concerns of physicians who may be reluctant to use an ARB in such patients, despite anticipated benefits." Further, they state, "We are not aware of any report about patients who developed angioedema while receiving ACE inhibition and who were subsequently treated with an ARB." A search of the literature would suggest otherwise. In the ARCHIVES in 1998, Van Rijnsoever et al² reported 13 cases of angioedema in patients taking losartan. Three of these individuals had previously reported angioedema while using an ACE inhibitor. Warner et al³ . . . [Full Text of this Article]

RELATED ARTICLES

Angioedema and AT1 Receptor Blockers: Proceed With Caution—Reply
Haralambos Gavras and Irene Gavras
Arch Intern Med. 2003;163(12):1489.
EXTRACT | FULL TEXT  

Are Patients Who Develop Angioedema With ACE Inhibition at Risk of the Same Problem With AT1 Receptor Blockers?
Irene Gavras and Haralambos Gavras
Arch Intern Med. 2003;163(2):240-241.
EXTRACT | FULL TEXT